Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pfizer Inc. Q3 Earnings: The Most Important Things to Know


Pfizer Inc. Q3 Earnings: The Most Important Things to Know

Pfizer's (NYSE: PFE) overall story so far in 2017 has been a mediocre one. The big pharma company's stock is up year to date, but barely half as much as the S&P 500 index. Although Pfizer topped earnings estimates in the first two quarters of 2017, its top-line growth was either weak or nonexistent. But even in the midst of general mediocrity, there has been some good news.

Investors were hoping for more good news when Pfizer announced its third-quarter earnings results before the market opened on Tuesday. And they got some. However, they also received some bad news, along with some so-so news as well. Here's what you need to know the most from Pfizer's third-quarter earnings results.

Image source: Getty Images.

Continue reading


Source: Fool.com

Pfizer Inc. Stock

€25.87
-0.250%
Pfizer Inc. shows a slight decrease today, losing -€0.065 (-0.250%) compared to yesterday.
The stock is one of the favorites of our community with 35 Buy predictions and 4 Sell predictions.
As a result the target price of 40 € shows a very positive potential of 54.62% compared to the current price of 25.87 € for Pfizer Inc..
Like: 0
PFE
Share

Comments